Drug Type Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC) |
Synonyms- |
Target |
Action modulators |
Mechanism CD276 modulators(CD276 antigen modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CD276 Positive Solid Tumors | Phase 1 | China | 01 Jan 2024 | |
Solid tumor | Phase 1 | China | 01 Jan 2024 |